A double-blind, placebo-controlled, parallel study to evaluate the effects of GW856553 on endothelial function/vascular compliance in subjects with dyslipidaemia.

Trial Profile

A double-blind, placebo-controlled, parallel study to evaluate the effects of GW856553 on endothelial function/vascular compliance in subjects with dyslipidaemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2012

At a glance

  • Drugs Losmapimod (Primary)
  • Indications Dyslipidaemias; Lipid metabolism disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Oct 2008 Actual start date changed from May 2007 to July 2007 as reported by Clinicaltrials.gov.
    • 12 Oct 2008 Trial phase changed from I/II to II as reported by ClinicalTrials.gov.
    • 23 Jan 2008 The expected completion date for this trial is now 1 Feb 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top